Not Signed In -
Drotrecogin alfa |
Xigris |
Image:Drotrecogin alfa.png Drotrecogin alfa Systematic (IUPAC) name Activated human protein C Identifiers CAS number 60202-16-6 ATC code B01AD10 PubChem ? DrugBank BTD00068 Chemical data Formula C1786H2779N509O519S29 Mol. weight 55000 g/mol Pharmacokinetic data Bioavailability 100 % (i.v. application only) Metabolism through endogenous plasma protease inhibitors Half life less than 2 hours Excretion ? Therapeutic considerations Pregnancy ca ...
Wikipedia - [full article]
Drotrecogin alfa Clinical Trials
- The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients with Severe Sepsis
ClinicalTrials.gov Identifier: NCT00045760 - Completed
Sepsis
- Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis
ClinicalTrials.gov Identifier: NCT00049764 - Completed
Sepsis
- Prophylactic Heparin during Xigris [Drotrecogin Alfa (Activated)] Treatment of High-Risk Severe Sepsis
ClinicalTrials.gov Identifier: NCT00049777 - Completed
Sepsis
- Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study
ClinicalTrials.gov Identifier: NCT00191724 - Recruiting
Submassive Pulmonary Embolism
- Evaluate Impact to Protein C Levels With Changing Dose/Duration of Drotrecogin Alfa (Activated) Administered to Severe Sepsis Patients
ClinicalTrials.gov Identifier: NCT00386425 - Recruiting
Severe Sepsis
- Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion
ClinicalTrials.gov Identifier: NCT00190788 - Completed
Sepsis; Hypotension
- The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of Death
ClinicalTrials.gov Identifier: NCT00568737 - Completed
Sepsis
- Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic Shock
ClinicalTrials.gov Identifier: NCT00279214 - Completed
Sepsis; Septic Shock
- D.O.S.E. Registry
ClinicalTrials.gov Identifier: NCT00212862 - Active, not recruiting
Cancer; Anemia; Epoetin Alfa; Darbepoetin Alfa
- Darbepoetin Alfa Compared With Epoetin alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
ClinicalTrials.gov Identifier: NCT00046982 - Active, not recruiting
Fatigue; Anemia; unspecified adult solid tumor, protocol specific
- Darbepoetin alfa Compared With Epoetin alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
ClinicalTrials.gov Identifier: NCT00070382 - Active, not recruiting
adult solid tumor; Anemia; Leukemia; Lymphoma; plasma cell neoplasm
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients
ClinicalTrials.gov Identifier: NCT00402428 - Active, not recruiting
Chronic Hepatitis C
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3
ClinicalTrials.gov Identifier: NCT00411385 - Active, not recruiting
Chronic Hepatitis C
- Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia
ClinicalTrials.gov Identifier: NCT00315484 - Active, not recruiting
Chemotherapy; Anemia
- Cost-Effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia
ClinicalTrials.gov Identifier: NCT00264108 - Recruiting
Neoplasms; Anemia
- Combination Chemotherapy Plus Interferon alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma
ClinicalTrials.gov Identifier: NCT00004039 - Active, not recruiting
Lymphoma
- Reduction of Immunosuppression Plus Interferon alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
ClinicalTrials.gov Identifier: NCT00002657 - Active, not recruiting
Lymphoma; Multiple Myeloma
- Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00002504 - Active, not recruiting
Lymphoma; Leukemia
- Interferon Alfa in Treating Children With HIV-Related Cancer
ClinicalTrials.gov Identifier: NCT00002621 - Active, not recruiting
Leukemia; Lymphoma
- A Safety and Efficacy Study of Prophylactically Administered Pegylated Interferon alfa-2a (Pegasys) plus Ribavirin vs. No Prophylaxis Following Liver Transplantation for Hepatitis C
ClinicalTrials.gov Identifier: NCT00087633 - Active, not recruiting
Hepatitis C
- Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy
ClinicalTrials.gov Identifier: NCT00416624 - Recruiting
Anemia; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Unspecified Adult Solid Tumor, Protocol Specific
- Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People
ClinicalTrials.gov Identifier: NCT00078442 - Active, not recruiting
HIV Infections
- A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients with Hepatitis C
ClinicalTrials.gov Identifier: NCT00118768 - Active, not recruiting
Chronic Hepatitis C
- Zidovudine Levels in HIV Infected Patients Being Treated for HCV
ClinicalTrials.gov Identifier: NCT00059358 - Active, not recruiting
HIV Infections; Hepatitis C
- Vaccine Therapy Compared With Interferon alfa in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00003715 - Active, not recruiting
stage III melanoma
- Interleukin-12 Followed by Interferon alfa in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00003451 - Active, not recruiting
Cancer
- Cisplatin, Interferon alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00003263 - Active, not recruiting
localized malignant mesothelioma
- A Study of Subjects with Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated with Platinum Plus Etoposide Chemotherapy with Or Without Darbepoetin Alfa
ClinicalTrials.gov Identifier: NCT00119613 - Active, not recruiting
Small Cell Lung Cancer
- SU011248 versus Interferon-alfa as First-Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma
ClinicalTrials.gov Identifier: NCT00083889 - Active, not recruiting
Renal Cell Carcinoma
- Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002868 - Active, not recruiting
chronic phase chronic myelogenous leukemia
- Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)
ClinicalTrials.gov Identifier: NCT00078403 - Active, not recruiting
HIV Infections; Hepatitis C; Liver Disease
- Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
ClinicalTrials.gov Identifier: NCT00040027 - Active, not recruiting
Hepatitis C; Hepatitis C, Chronic
- Radiation Therapy With or Without Epoetin alfa in Treating Patients With Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00017277 - Active, not recruiting
Oral Cancer; Throat Cancer
- Interferon alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas
ClinicalTrials.gov Identifier: NCT00002965 - Active, not recruiting
recurrent adult brain tumor
- Interferon alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002767 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma; Quality of Life
- A Study of Four Dosing Regimens of PROCRIT® (Epoetin Alfa) in Patients with Chronic Kidney Disease
ClinicalTrials.gov Identifier: NCT00212875 - Active, not recruiting
Kidney Diseases; Injections, Subcutaneous; Anemia
- Vaccine Therapy Plus Interleukin-2 With or Without Interferon alfa-2b in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00004104 - Active, not recruiting
stage III melanoma
- Interferon alfa Following Surgery in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00006249 - Active, not recruiting
stage III melanoma
- Interferon alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin
ClinicalTrials.gov Identifier: NCT00003444 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00052221 - Active, not recruiting
unspecified adult solid tumor, protocol specific; Fatigue
- Combination Chemotherapy With or Without Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00003027 - Active, not recruiting
Stage IV Melanoma
- Dexamethasone Plus Interferon alfa in Treating Patients With Primary Systemic Amyloidosis
ClinicalTrials.gov Identifier: NCT00002849 - Active, not recruiting
primary systemic amyloidosis
- Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer
ClinicalTrials.gov Identifier: NCT00019474 - Active, not recruiting
Pancreatic Cancer; Gastric Cancer; adult primary liver cancer
- Darbepoetin alfa in Treating Anemia in Patients With Cancer Who Are Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00039247 - Active, not recruiting
Anemia; unspecified adult solid tumor, protocol specific
- High-Dose or Low-Dose Interferon alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00002763 - Active, not recruiting
stage III melanoma; Recurrent Melanoma
- Epoetin alfa With or Without Filgrastim Compared With Blood Transfusions in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00003138 - Active, not recruiting
Anemia; Myelodysplastic Syndromes; Quality of Life
- A Study to Investigate the Neuroprotective Effect of PROCRIT® (Epoetin Alfa) Versus Placebo in Ovarian Cancer Patients Who Develop Chemotherapy-Induced Peripheral Neuropathy
ClinicalTrials.gov Identifier: NCT00267007 - Active, not recruiting
Peripheral Neuropathy, Chemotherapy-Induced; Ovarian Cancer
- Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus with Standard Treatment
ClinicalTrials.gov Identifier: NCT00006164 - Active, not recruiting
Chronic Hepatitis C; Cirrhosis, Liver; Fibrosis, Liver; Hepatic Cirrhosis
- Interferon alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00002882 - Active, not recruiting
stage III melanoma
- Combination Chemotherapy and Interferon alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma
ClinicalTrials.gov Identifier: NCT00002599 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue
ClinicalTrials.gov Identifier: NCT00004914 - Active, not recruiting
Anemia; unspecified adult solid tumor, protocol specific; Fatigue
- Interferon alfa Plus Radiation Therapy in Treating Patients With Stage III or Recurrent Melanoma That Has Been Removed by Surgery
ClinicalTrials.gov Identifier: NCT00005615 - Active, not recruiting
stage III melanoma; Recurrent Melanoma
- Combination Chemotherapy, Interferon alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002669 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Interferon alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00053820 - Active, not recruiting
Stage IV Renal Cell Cancer
- Epoetin alfa in Treating Anemia in Patients With Solid Tumors
ClinicalTrials.gov Identifier: NCT00058331 - Active, not recruiting
adult solid tumor; Anemia; Leukemia; Lymphoma; plasma cell neoplasm
- Epoetin alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy
ClinicalTrials.gov Identifier: NCT00003341 - Active, not recruiting
Lymphoma; Leukemia; Multiple Myeloma
- PEG-Interferon alfa-2b in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00045279 - Active, not recruiting
Stage IV Renal Cell Cancer
- Epoetin alfa in Treating Cancer-Related Anemia in Patients With Non-Myeloid Cancer Who Are Not Currently Receiving Chemotherapy or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00090935 - Active, not recruiting
adult solid tumor; Anemia; Leukemia; Lymphoma; plasma cell neoplasm
- Interleukin-12 and Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00026143 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer
ClinicalTrials.gov Identifier: NCT00146562 - Active, not recruiting
Breast Cancer; stage I breast cancer; Stage II breast cancer
- Tretinoin Plus Interferon alfa in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003656 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Interferon alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00062010 - Active, not recruiting
Recurrent Small Cell Lung Cancer
- Radiation Therapy With or Without Epoetin alfa in Anemic Patients With Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00004917 - Active, not recruiting
Anemia; Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
- Temozolomide plus PEG-Interferon alfa-2B in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00014261 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Advanced Renal Cell Carcinoma
ClinicalTrials.gov Identifier: NCT00065468 - Active, not recruiting
Carcinoma, Renal Cell; Kidney Neoplasms
- Combination Chemotherapy With or Without Interferon alfa in Treating Patients With Previously Untreated Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00002556 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Epoetin alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00060398 - Active, not recruiting
recurrent prostate cancer; Anemia; Fatigue
- Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon alfa in Treating Patients With Recurrent Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00002734 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- PEG-Interferon alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00090870 - Active, not recruiting
Stage IV Renal Cell Cancer
- Sorafenib With or Without Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00126594 - Active, not recruiting
renal clear cell carcinoma; Stage IV Renal Cell Cancer
- Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study)
ClinicalTrials.gov Identifier: NCT00168909 - Active, not recruiting
Osteoporosis
- Interferon alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
ClinicalTrials.gov Identifier: NCT00004196 - Active, not recruiting
stage I melanoma; stage II melanoma; stage III melanoma
- Oblimersen and Interferon alfa in Treating Patients With Metastatic Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00059813 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Interferon alfa in Treating Patients With Advanced Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003542 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
- Amifostine With or Without Epoetin alfa in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00003681 - Active, not recruiting
Refractory Anemia; Previously Treated Myelodysplastic Syndrome; Anemia; secondary myelodysplastic syndrome; ...
- Interferon alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00002847 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- A Phase I Trial of Peginterferon alfa-2b (PEG-Intron) for Plexiform Neurofibromas
ClinicalTrials.gov Identifier: NCT00156754 - Recruiting
- Darbepoetin alfa in Treating Anemic Patients With Myelodysplastic Syndromes
ClinicalTrials.gov Identifier: NCT00093691 - Recruiting
Anemia; Fatigue; Myelodysplastic Syndromes
- Interferon alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer
ClinicalTrials.gov Identifier: NCT00005966 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
- Interferon alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00002737 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer; Renal Cell Adenocarcinoma
- Interleukin-2, Interferon alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer
ClinicalTrials.gov Identifier: NCT00053807 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
- Isotretinoin, Interferon alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00054561 - Active, not recruiting
Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
- Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
ClinicalTrials.gov Identifier: NCT00017004 - Active, not recruiting
Anemia; Cervical Cancer; Drug Toxicity; Quality of Life; radiation toxicity
- Adjuvant Chemoradiotherapy and Interferon alfa in Treating Patients With Resected Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00059826 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- Interferon alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002869 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
- Combination Chemotherapy and Interferon alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00004897 - Active, not recruiting
squamous cell carcinoma of the esophagus; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage I esophageal cancer; ...
- Azacitidine and Interferon Alfa in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00398450 - Active, not recruiting
Melanoma (Skin)
- Interferon alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma
ClinicalTrials.gov Identifier: NCT00002892 - Active, not recruiting
stage III melanoma; Recurrent Melanoma; childhood skin cancer; stage II melanoma
- Vaccine Therapy Combined With Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer)
ClinicalTrials.gov Identifier: NCT00085436 - Active, not recruiting
recurrent renal cell cancer; Stage IV Renal Cell Cancer
- The Effect of PROCRIT (Epoetin Alfa) on Postoperative Vigor and Handgrip Strength (VIGOR Study)
ClinicalTrials.gov Identifier: NCT00401869 - Active, not recruiting
Anemia
- Vitamin A and Response to Endotoxin
ClinicalTrials.gov Identifier: NCT00168649 - Active, not recruiting
TNF-Alfa; Endotoxin Levels
- Treatment of Chronic Anemia With Epoetin Alfa in Elderly
ClinicalTrials.gov Identifier: NCT00337441 - Active, not recruiting
Anemia
- STI571 Compared With Interferon alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00006343 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; Quality of Life
- High-Dose Interferon alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma
ClinicalTrials.gov Identifier: NCT00003091 - Active, not recruiting
Stage IV Melanoma; Stage IV Renal Cell Cancer; recurrent renal cell cancer; Recurrent Melanoma
- Time of Ventilation and Lung Function of Ventilated Patients Under Therapy With Dornase Alfa
ClinicalTrials.gov Identifier: NCT00204685 - Active, not recruiting
Long Term Ventilation
- Interferon alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
ClinicalTrials.gov Identifier: NCT00072046 - Active, not recruiting
Stage IV Renal Cell Cancer; renal clear cell carcinoma; recurrent renal cell cancer
- A Study Comparing Mircera and Epoetin Alfa for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.
ClinicalTrials.gov Identifier: NCT00422513 - Active, not recruiting
Anemia
- Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00015912 - Active, not recruiting
recurrent grade I follicular small cleaved cell lymphoma; recurrent grade II follicular mixed cell lymphoma
- Sunitinib Malate Alone and in Combination With Interferon Alfa as First-Line Therapy for Metastatic Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00267748 - Recruiting
Renal Cell Carcinoma
- Temozolomide and Interferon alfa in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00027742 - Active, not recruiting
iris melanoma; extraocular extension melanoma; recurrent intraocular melanoma; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
Resources
- Drotrecogin alfa (Drug Digest)
- Xigris (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
